Clinical Trials Directory

Trials / Completed

CompletedNCT03185546

Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors

Project 2: The Impact of Cigarette Nicotine Content, E-cigarette Nicotine Content, and E-cigarette Flavoring on Smoking Behavior

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
156 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Project 2 will evaluate the impact of very low nicotine content cigarettes, e-cigarette nicotine content, and e-cigarette flavoring on cigarettes smoked per day, nicotine exposure, puff topography, discomfort/dysfunction, other health-related behaviors, nicotine/tobacco dependence, biomarkers of tobacco exposure, intention to quit, compensatory smoking, other tobacco use, cardiovascular function, and perceived risk. Project 2 will also evaluate differences between conditions in compliance with product use and the ability to abstain from cigarette smoking when provided a financial incentive for abstinence from combusted tobacco. This is not a treatment program for smoking.

Conditions

Interventions

TypeNameDescription
OTHERNNC Spectrum CigaretteParticipants are provided with normal nicotine content Spectrum Cigarette for 13 weeks.
OTHERVLNC Spectrum CigaretteParticipants are provided with very low nicotine content Spectrum Cigarette for13 weeks
OTHERModerate nicotine level e-liquidParticipants are provided with moderate nicotine level e-liquid for 13 weeks
OTHERLow nicotine level e-liquidParticipants are provided with very low or nicotine-free nicotine level e-liquid for 13 weeks
OTHERTobacco FlavorsParticipants can choose e-liquid flavors from a selection of tobacco flavors
OTHERTobacco and non-tobacco e-liquid flavorsParticipants can choose e-liquid flavors from a selection of flavors that includes tobacco and non-tobacco choices

Timeline

Start date
2018-08-06
Primary completion
2020-03-13
Completion
2020-03-13
First posted
2017-06-14
Last updated
2021-05-14
Results posted
2021-05-14

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03185546. Inclusion in this directory is not an endorsement.